 |
Witnesses: John E. Calfee, Ph.D., Resident Scholar, American Enterprise Institute; Nancy Chockley, Pres., National Institute for Health Care Management; Mark Cloutier, Policy Director, RxHealth Value; Richard Dolinar, Endocrinologist, Endocrinologist Associates; Gregory J. Glover, M.D., J.D., on behalf of The Pharmaceutical Research & Manufacturers of America; Nancy Ostrove, Ph.D., Deputy Director, Division of Drug Marketing, Advertising, & Communications. Food & Drug Administration (FDA); Michael S. Shaw, Executive Director, EthicAd; & Sidney M. Wolfe, M.D., Director, Public Citizen’s Health Research Group. Illustrations.
|
|
|
